How much funding has Advion BioSciences raised?

Advion BioSciences has raised $15.0M in total funding, most recently a Series B round.

Who are Advion BioSciences's investors?

Advion BioSciences's investors include Polaris Partners.

When was Advion BioSciences founded?

Advion BioSciences was founded in 1993.

Where is Advion BioSciences headquartered?

Advion BioSciences is headquartered in Ithaca, New York, United States.

What industry is Advion BioSciences in?

Advion BioSciences operates in Biotech, Healthcare.

How many employees does Advion BioSciences have?

Advion BioSciences has 201-500 employees.

Advion BioSciences

Ithaca, United States · Founded 1993 · $15.0M raised

Biotech

Healthcare

Headquarters: Ithaca, New York
Employees: 201–500
Founded: 1993
Business Model: B2B

Total Funding: $15.0M
Last Round: $15.0M Series BMay 2002
Rounds: 1

About

Advion BioSciences (now Advion Interchim Scientific) is a leading developer and manufacturer of mass spectrometry instruments, chip-based ion sources, microfluidic flow chemistry systems, and scientific consumables for laboratory research. Founded in 1993 based on novel techniques developed within the Cornell University laboratory of Dr. Jack Henion, the company is headquartered in Ithaca, New York. Over more than three decades, Advion has built a broad portfolio of chemist-centric, purpose-built mass spectrometers — including the expression CMS compact mass spectrometer, the SOLATION ICP-MS, the AVANT UHPLC, and the TriVersa NanoMate nanoelectrospray ionization source — serving academic, pharmaceutical, biopharmaceutical, and clinical clients worldwide. The company merged with French chromatography specialist Interchim to become Advion Interchim Scientific.

Summary

Advion BioSciences is a Biotech company based in Ithaca, United States, founded in 1993. It has raised $15.0M in total across 1 round, most recently a $15.0M Series B round in May 2002. Investors include Polaris Partners.